Survival Outcomes in the Canadian Merkel Cell Carcinoma Population Between 2000 and 2018 and Descriptive Comparison with the American Joint Committee on Cancer 8th Edition Staging System—A Study from the Pan-Canadian Merkel Cell Collaborative
Brittany Dingley(Ontario Institute for Cancer Research), Carolyn Nessim(University of Ottawa), Jessika Hetu(Université de Sherbrooke), Ari N. Meguerditchian, Olivia Hershorn(Manitoba Health), Angela E. Schellenberg(Mount Sinai Hospital), Evan Jost(University of Calgary), Érica Patocskai(Centre Hospitalier de l’Université de Montréal), Samuel Rodriguez-Qizilbash(Centre Hospitalier de l’Université de Montréal), Eva Thiboutot(University of Calgary), Julie La(Queen's University), Alexandra Easson(Princess Margaret Cancer Centre), Kaitlin Vanderbeck(Queen's University), Trevor D. Hamilton(Vancouver General Hospital), Megan Delisle(University of Ottawa), Pamela Hebbard(University of Manitoba), David Berger‐Richardson(University of Toronto), Sameer Apte, Farisa Hossain(Memorial University of Newfoundland), Valerie Francescutti(Hamilton Health Sciences), Anne Light(University of Ottawa), Heather Stuart(University of Miami), Shaila J. Merchant(Queen's University), Vanina Tchuente(University Health Network), Suzanne Kazandjian(Centre Hospitalier de l’Université de Montréal), Frances C. Wright(Sunnybrook Health Science Centre), Gregory McKinnon(Saint John's Health Center), Rami Younan(Centre Hospitalier de l’Université de Montréal), Martha Talbot(Vancouver General Hospital), Stephanie Johnson‐Obaseki(University of Ottawa), Alex Mathieson(Memorial University of Newfoundland), Ranjeeta Mallick(University of Ottawa)
Cited by 1
Related Papers
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale
|International Journal of Cancer|2020|474
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial
|The Lancet Oncology|2019|459
Prevalence, Risk Factors, and Outcomes of Delirium in Mechanically Ventilated Adults*
|Critical Care Medicine|2014|341